Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial (ShareIT)

Louise Farrer

Status and phase: Withdrawn; Early Phase 1

Conditions: Depression

Treatments: Other: bulletin board

Study type: Interventional

Funder types: Other

Identifiers

NCT01423448

NHMRC Fellowship ref 525413 (Other Grant/Funding Number)

CMHR-123

Details and patient eligibility

About

This study is a randomised controlled trial that aims to examine the efficacy of an established online bulletin board for depression. It has been estimated that millions of people worldwide use peer-to-peer bulletin boards, forums or internet support groups (ISGs) for health conditions. However, little is known about the effectiveness of these groups in terms of symptom reduction or improvement in quality of life. The current project investigates the effectiveness of an established online bulletin board for depression available to the public. To our knowledge, this is the first randomised controlled trial of the effectiveness of a pre-existing, well-established online bulletin board for depression in the community. The aims of the project are to determine whether the bulletin board improves mental health, quality of life, and related outcomes among members of the community with high levels of self-reported psychological distress and previous history or current experience of depression.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Over 18 years of age
2. Internet access with email
3. Self-report of current or previous experience of depression

Exclusion criteria

1. Current participation in an online support group for depression
2. Diagnosis of bipolar disorder, schizophrenia, or psychosis

Trial design

0 participants in 2 patient groups

Bulletin board

Experimental group

Description:

Participants will be given access to the online bulletin board (intervention) for a 6 month period

Treatment:

Other: bulletin board

Control

No Intervention group

Description:

After 6 months participants allocated to the control group will receive access to the intervention